We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+15.65%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$23.7B
AUM Growth
+$6.7B
(+39%)
Cap. Flow
+$3.87B
Cap. Flow
% of AUM
16.32%
Top 10 Holdings %
Top 10 Hldgs %
42.3%
Holding
1,113
New
41
Increased
800
Reduced
228
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.89B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$702M |
| 3 |
Qualcomm
QCOM
|
+$111M |
| 4 |
Apple
AAPL
|
+$86.9M |
| 5 |
Microsoft
MSFT
|
+$85.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$64.2M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$55.5M |
| 3 |
Intel
INTC
|
+$44M |
| 4 |
Advanced Micro Devices
AMD
|
+$29.1M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$17.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.04% |
| 2 | Financials | 10.33% |
| 3 | Healthcare | 6.19% |
| 4 | Consumer Discretionary | 4.07% |
| 5 | Energy | 2.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
SiriusXM
SIRI
$9.98B
| $11M | 0.05% |
200,354
-10,950
| -5% | -$526K |
|
252
Roivant Sciences
ROIV
$24.5B
| $10.9M | 0.05% |
973,134
+195,136
| +25% | +$1.9M |
|
|
SPLK
253
DELISTED
Splunk Inc
SPLK
| $10.8M | 0.05% |
+70,916
| New | +$10.6M |
|
|
MRO
254
DELISTED
Marathon Oil Corporation
MRO
| $10.8M | 0.05% |
445,598
+15,188
| +4% | +$391K |
|
255
Recursion Pharmaceuticals
RXRX
$1.59B
| $10.7M | 0.05% |
1,090,173
-14,353
| -1% | -$102K |
|
256
Northrop Grumman
NOC
$77.1B
| $10.7M | 0.05% |
22,878
+1,006
| +5% | +$472K |
|
257
Oneok
OKE
$57.2B
| $10.7M | 0.05% |
151,978
-2,019
| -1% | -$135K |
|
258
Pinduoduo
PDD
$126B
| $10.7M | 0.05% |
72,931
-11,836
| -14% | -$1.44M |
|
259
Prosperity Bancshares
PB
$8.97B
| $10.6M | 0.04% |
157,131
+49,533
| +46% | +$2.9M |
|
260
Ultragenyx Pharmaceutical
RARE
$2.45B
| $10.6M | 0.04% |
221,910
+38,859
| +21% | +$1.51M |
|
261
Mercado Libre
MELI
$95.2B
| $10.6M | 0.04% |
6,736
+699
| +12% | +$991K |
|
|
AKRO
262
DELISTED
Akero Therapeutics
AKRO
| $10.6M | 0.04% |
451,832
+268,335
| +146% | +$5.29M |
|
263
MongoDB
MDB
$27.1B
| $10.5M | 0.04% |
+25,752
| New | +$9.77M |
|
264
Revolution Medicines
RVMD
$39.9B
| $10.5M | 0.04% |
365,095
+138,153
| +61% | +$3.32M |
|
265
Krystal Biotech
KRYS
$10.1B
| $10.4M | 0.04% |
84,021
+12,215
| +17% | +$1.35M |
|
|
DFS
266
DELISTED
Discover Financial Services
DFS
| $10.4M | 0.04% |
92,598
+5,131
| +6% | +$474K |
|
267
Trade Desk
TTD
$8.48B
| $10.4M | 0.04% |
144,466
+43,350
| +43% | +$3.18M |
|
268
General Dynamics
GD
$104B
| $10.4M | 0.04% |
39,948
+1,423
| +4% | +$347K |
|
269
CVS Health
CVS
$133B
| $10.3M | 0.04% |
130,738
-3,280
| -2% | -$233K |
|
270
Stryker
SYK
$125B
| $10.3M | 0.04% |
34,415
-852
| -2% | -$239K |
|
|
EXAS
271
DELISTED
Exact Sciences
EXAS
| $10.3M | 0.04% |
138,719
+25,103
| +22% | +$1.65M |
|
272
TransDigm Group
TDG
$70.2B
| $10.2M | 0.04% |
10,123
+675
| +7% | +$623K |
|
273
APA Corp
APA
$13.2B
| $10.2M | 0.04% |
284,719
+36,721
| +15% | +$1.39M |
|
274
Iovance Biotherapeutics
IOVA
$1.82B
| $10.1M | 0.04% |
1,247,515
-248,655
| -17% | -$1.3M |
|
275
Equinix
EQIX
$101B
| $10.1M | 0.04% |
12,591
+2,142
| +20% | +$1.64M |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q4 2023 Portfolio in Review
As of Q4 2023, Rafferty Asset Management held 1,113 positions worth $23.7B, up 39% from $17B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Rafferty Asset Management deployed $3.87B of net new capital in Q4 2023, opening 41 new positions and adding to 800 existing holdings. Its largest new stake was Splunk Inc: 70,916 shares worth $10.8M.
By sector, the portfolio is most concentrated in Technology at 40% of assets, down from 43% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $64.2M trimmed.
- Rafferty Asset Management's largest Q4 2023 buy was Splunk Inc: 70,916 shares worth $10.8M.
- Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q4 2023, an estimated $1.89B increase.
- Rafferty Asset Management's biggest Q4 2023 reduction was Texas Instruments, cutting an estimated $64.2M.
- Rafferty Asset Management fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $17.8M.
- Rafferty Asset Management's ten largest holdings make up 42% of its $23.7B portfolio in Q4 2023.
- Rafferty Asset Management opened 41 new positions and closed 43 in Q4 2023.
- Rafferty Asset Management's portfolio value rose 39% quarter-over-quarter to $23.7B.
Based on Rafferty Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.